<html>
	<head>
		<title>hunterdon <hunt> sets dental venture</title>
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>hunterdon pharmaceuticals inc said it formed a joint venture with <chesapeake biological laboratories> and <e.b. michaels research associates> to develop c31g, a substance that may be useful in the treatment or prevention of plaque.     the substance, tested in pre-clinical trials at the university of pennsylvania, also has other uses as an anti-fungal or anti-bacterial agent, the company said.     it said chesapeake biological, a private company, owns 55 pct of the venture, e.b. michaels 10 pct, while it holds the remaining interest, and the patent for c31g.  reuter &#3;</h3>
</body>
</html>